Viridian Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Viridian Therapeutics, Inc. (VRDN) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.100.100.160.040.050.030.06
Short-Term Investments0.620.370.270.150.080.000.00
Cash & Short-Term Investments0.720.480.420.200.130.030.06
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.020.010.010.000.000.000.00
Total Current Assets0.740.490.430.200.130.030.07
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.000.000.000.000.000.000.00
Total Assets0.740.490.440.200.130.030.07
Current Liabilities
Accounts Payable0.000.000.010.000.000.010.00
Short-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities0.030.010.020.010.010.000.00
Deferred Revenue0.000.000.000.000.000.000.00
Other Current Liabilities0.000.000.000.000.000.000.00
Total Current Liabilities0.050.030.030.010.010.010.01
Non-Current Liabilities
Long-Term Debt0.020.020.000.000.000.000.01
Other Non-Current Liabilities0.000.000.000.000.000.000.00
Total Non-Current Liabilities0.020.020.010.000.000.000.01
Total Liabilities0.070.050.040.020.010.010.01
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.00-0.73-0.49-0.36-0.28-0.17-0.13
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.480.960.740.410.220.180.18
Shares Outstanding0.080.050.040.020.000.000.00
Total Stockholders' Equity0.670.440.400.190.120.020.05
Total Liabilities & Equity0.740.490.440.200.130.030.07